Document is current
Any future updates will be listed below
-
Authors
Bozzalla Cassione, Emanuele https://orcid.org/0000-0001-6578-6938
Mansoubi, Mehrad https://orcid.org/0000-0001-6330-5643
Mazzucchelli, Iolanda
Luvaro, Terenzj https://orcid.org/0000-0003-3187-3843
De Stefano, Ludovico https://orcid.org/0000-0002-2312-2161
Xoxi, Blerina https://orcid.org/0000-0003-3247-0683
Grignaschi, Silvia https://orcid.org/0000-0003-0234-9030
Bugatti, Serena https://orcid.org/0000-0002-5396-7077
Montecucco, Carlomaurizio https://orcid.org/0000-0001-8263-3925
Manzo, Antonio https://orcid.org/0000-0002-9743-6008
- License Information
-
More Information
Article History
Received: 26 May 2022
Revised: 10 June 2022
Accepted: 14 June 2022
First Online: 22 June 2022
Declarations
:
: The study was approved by the Local Ethical Committee of the IRCCS Policlinico San Matteo Foundation, Pavia, Italy (n.20070001302).
: SB reports grant/research support from: Pfizer, and personal fees from: AbbVie, Bristol-Myers Squibb, Eli Lilly, Gilead, Pfizer, Sanofi. CM reports personal fees from: AbbVie, Bristol-Myers Squibb, Eli Lilly, Gilead, Pfizer, Roche, Sanofi.
: Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.
